Deutsche Bank Reiterates Buy on Eli Lilly, Maintains $1025 Price Target
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst James Shin has reiterated a Buy rating on Eli Lilly (NYSE:LLY) and maintained a price target of $1025.
October 03, 2024 | 5:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank analyst James Shin has reiterated a Buy rating on Eli Lilly and maintained a price target of $1025, indicating confidence in the company's future performance.
The reiteration of a Buy rating and a high price target by a reputable analyst suggests a positive outlook for Eli Lilly's stock, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100